Posted December 28th, 2020 for Imarc Group The GCC generic injectables market is driven by the collaboration between domestic manufacturers and regional and international players, coupled with the growing number of generic drug manufacturing facilities in the region. North Bergen, New Jersey, United States., December 28, 2020 - /PressReleasePoint/ - According to the latest report by IMARC Group, titled “ GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the GCC generic injectables market size reached US$ 500 Million in 2019. Generic injectables refer to drugs that have the same active ingredients, strength, dosage and route of administration as that of branded injectables. In the GCC countries, the demand for injectables is rising as they help to increase patient compliance without compromising the effectiveness of the treatment. Moreover, the lower cost of these injectables, as compared to their branded equivalents, helps in providing substantial savings for both the patients and healthcare providers.